Citations

Showing 10 of 108119 citations.

Diabetes Remission After Bariatric Surgery in Patients on Glucocorticoids: A Pilot Study
Vahibe, Ahmet, Livia, Christopher, Portela, Ray, Shah, Meera, McKenzie, Travis, Kellogg, Todd, Ghanem, Omar M., Portela, Ray , Vahibe, Ahmet, Livia, Christopher, Shah, Meera, McKenzie, Travis, Kellogg, Todd, Ghanem, Omar M.

Mayo Clinic

Surgical Laparoscopy, Endoscopy & Percutaneous Techniques | December 30, 2021 | Volume: 32 | Issue: 2 | Pages: 236-240

10.1097/sle.0000000000001028 | PMID 34966151 Get It

Background: Diabetes mellitus type 2 (DM2) remission after bariatric surgery has long been reported in the medical literature. Glucocorticoid use is associated with weight gain and could theoretically affect diabetes remission post bariatric surgery. Objectives: The aim is to identify remission rates of DM2 among patients using glucocorticoids after bariatric surgery and assess long-term postsurgical follow-up. Methods: A retrospective analysis was performed on patients who used glucocorticoids and underwent bariatric surgery at the Mayo Clinic between 2008 and 2020. Data were analyzed for 3-month, 6-month, 1-year, 2-year, and 5-year intervals for factors indicative of diabetes remission. Results: Within our retrospective search, we identified 92 patients who were on any immunosuppressant medication before surgery. Of those, 22 patients had a diagnosis of DM2 while 18 of them were concurrently on glucocorticoids. Diabetes remission occurred in 11 of the 18 DM2 patients (61.11%). There was a statistically significant negative correlation between diabetes remission and combination therapy with glucocorticoids and tacrolimus (P=0.016); patients with a longer duration of DM2 diagnosis (P=0.024), and patients who used insulin three months after the procedure (P=0.001). However, percent total weight loss and the number of preoperative oral DM2 medications were not associated with worse outcomes. Conclusions: Patients who use systemic glucocorticoids are able to achieve diabetes remission after bariatric surgery. Concurrent therapy with tacrolimus is associated with worse remission outcomes.
Investigation of creep properties and the cytoskeletal structures of non‐tumorigenic breast cells and triple‐negative breast cancer cells
Onwudiwe, Killian , Obayemi, John D. , Hu, Jingjie , Oparah, Josephine C. , Onyekanne, Chinyerem E., Nwazojie, Chukwudalu C., Aina, Toyin , Uzonwanne, Vanessa O., Salifu, Ali A. , Soboyejo, Winston O.

Mayo Clinic

Journal of Biomedical Materials Research Part A | December 30, 2021 | Volume: 110 | Issue: 5 | Pages: 1004-1020

10.1002/jbm.a.37348 | PMID 34967111 Get It

AbstractThis article presents the correlation of creep and viscoelastic properties to the cytoskeletal structure of both tumorigenic and non‐tumorigenic cells. Unique shear assay and strain mapping techniques were used to study the creep and viscoelastic properties of single non‐tumorigenic and tumorigenic cells. At least 20 individual cells, three locations per cell, were studied. From the results, lower densities in the volume of actin, and keratin 18 structures were observed with the progression of cancer and were correlated to the increased creep rates and reduced mechanical properties (Young's moduli and viscosities) of tumorigenic (MDA‐MB‐231) cells. The study reveals significant differences between the creep and viscoelastic properties of non‐tumorigenic breast cells versus tumorigenic cells. The variations in the creep strain rates are shown to be well characterized by lognormal distributions, while the statistical variations in the viscoelastic properties are well‐described by normal distributions. The implications of the results are discussed for the study of discrete cell behaviors, strain and viscoelastic responses of the cell, and the role of cell cytoskeleton in the onset and progression of cancers.
Reply: Using Artificial Intelligence to Measure Facial Expression following Facial Reanimation Surgery
Boonipat, Thanapoom, Asaad, Malke, Lin, Jason, Glass, Graeme E., Mardini, Samir, Stotland, Mitchell, Stotland, Mitchell A. , Boonipat, Thanapoom, Asaad, Malke, Lin, Jason, Glass, Graeme E., Mardini, Samir

Mayo Clinic

Plastic & Reconstructive Surgery | December 29, 2021 | Volume: 149 | Issue: 2 | Pages: 345e-346e

10.1097/prs.0000000000008757 | PMID 34965240 Get It

Sarcina ventriculi in an Endoscopic Ultrasound-Guided Fine Needle Aspiration of a Perigastric Lymph Node with Metastatic Pancreatic Adenocarcinoma: A Carry-Through Contaminant Bacterial Microorganism from the Stomach
Nandakumar, Bharat , Salomão, Diva R. , Boire, Nicholas, Sturgis, Charles D. , Boire, Nicholas A, Sturgis, Charles D , Schuetz, Audrey N.

Mayo Clinic

Case Reports in Pathology | December 29, 2021 | Volume: 2021 | Issue: No issue available | Pages: 1-5

10.1155/2021/4933279 | PMID 35003818 Get It

Sarcina ventriculi is a rare gram-positive coccus increasingly reported in patients with a history of delayed gastric emptying or gastric outlet obstruction and is sometimes seen in association with emphysematous gastritis and perforation. We report a case of a 67-year-old male who presented with epigastric pain. CT imaging and cholangiopancreatography were concerning for pancreatic neoplasia. Upper endoscopic ultrasound-guided fine needle aspiration cytology of a perigastric lymph node confirmed metastatic adenocarcinoma of pancreatic origin, and cocci arranged in a tetrad fashions characteristic of Sarcina ventriculi were noted. To our knowledge, this is the first reported case of Sarcina ventriculi in an FNA of metastatic pancreatic carcinoma in a perigastric lymph node. These organisms likely represent carry-through contaminants from the transgastric approach of the endoscopic FNA.
Association Between Area-Level Socioeconomic Deprivation and Diabetes Care Quality in US Primary Care Practices
Funni, Shealeigh A., Giblon, Rachel , Inselman, Jonathan , Shah, Nilay D. , Allen, Summer V. , Rushlow, David , Kurani, Shaheen Shiraz, Lampman, Michelle A. , Giblon, Rachel E., Inselman, Jonathan W, Allen, Summer , Kurani, Shaheen , McCoy, Rozalina G.

Mayo Clinic

JAMA Network Open | December 29, 2021 | Volume: 4 | Issue: 12 | Pages: e2138438

10.1001/jamanetworkopen.2021.38438 | PMID 34964856 Get It

Can older patients adopt and maintain a ketogenic diet? An observational study in support of clinical trials in older patients
Almodallal, Yahya, Cook, Kathryn, Lammert, Lisa M., Lee, Minji, Le-Rademacher, Jennifer G., Jatoi, Aminah , Almodallal, Yahya , Cook, Kathryn, Lammert, Lisa M., Lee, Minji, Le-Rademacher, Jennifer G., Jatoi, Aminah

Mayo Clinic

Medicine | December 29, 2021 | Volume: 100 | Issue: 47 | Pages: e28033

10.1097/md.0000000000028033 | PMID 34964801 Get It

Abstract Ketogenic diets appear promising for obesity, diabetes, cancer, and other illnesses. Because older patients are more likely to contend with such illnesses and because of a paucity of dietary outcomes among these patients, we examined ketogenic diets in older patients. This multisite study focused on patients (≥65 years of age) on a ketogenic diet. Medical records were identified with the keywords “keto,” “ketogenic,” and “Atkins.” Records were reviewed in detail with extraction of direct quotations to substantiate observations. We report on 200 consecutive patients with a median age of 70 years. Reasons for diet included weight loss, diabetes, and cancer; the majority remained on the diet for >1 month. In 134 (67%: 95% confidence interval: 60, 73%), the ketogenic diet appeared beneficial: 93 of 117 (79%) who sought weight loss lost weight (“She has lost 15 pounds and plans to lose another 8”); 36 of 67 (54%) who sought glucose control appeared to achieve the latter (“He has gone on a ketogenic diet and has been able to bring his sugars down significantly”); and 5 of 8 (63%) who sought improved cancer outcomes appeared to derive them (“He attributes part of the control of his cancer and increased QOL to adopting the keto for cancer diet”). Adverse events occurred in 30 patients (15%): dyslipidemia (n = 14), constipation (n = 9), sub-therapeutic international normalized ratio (n = 3), pancreatitis (n = 2), diarrhea (n = 1), and fatigue (n = 1). Trials that test ketogenic diets for a variety of illnesses should enroll older adults.
Detecting cardiomyopathies in pregnancy and the postpartum period using ECG
Douglass, Erika J. , Phillips, Sabrina D. , Yamani, Mohamad H. , Connolly, Heidi M. , Rose, Carl H., Friedman, Paul A. , Carter, R E, Adedinsewo, Demilade , Johnson, Patrick W. , Attia, Zachi I. , Goswami, Rohan , Sharpe, Emily E. , López-Jiménez, Francisco , Noseworthy, Peter A.

Mayo Clinic

European Heart Journal - Digital Health | December 29, 2021 | Volume: 2 | Issue: 4 | Pages: No page available

10.1093/ehjdh/ztab104.3062 Get It

Abstract Background Cardiovascular disease (CVD) has been identified as a major threat to maternal health in the US and UK with cardiomyopathy being one of the most common acquired CVD in the pregnant and postpartum period. Diagnosing cardiomyopathy in pregnancy is challenging due to an overlap of cardiovascular symptoms with normal pregnancy symptoms. Purpose The purpose of this study was to evaluate the effectiveness of an ECG based deep learning model in identifying cardiomyopathy among pregnant and postpartum women. Methods We utilized an ECG based deep learning model to detect cardiomyopathy in a cohort of pregnant or postpartum women seen at multiple hospital sites. Model performance was evaluated using area under the curve (AUC), accuracy, sensitivity, and specificity. We compared the diagnostic probabilities of the deep learning model with natriuretic peptides and a multivariable model consisting of demographic and clinical parameters. Results 1,807 women were included. 7%, 10% and 13% had LVEF ≤35%, <45% and <50% respectively. The ECG based deep learning model identified cardiomyopathy with an AUC of 0.92 for left ventricular ejection fraction (LVEF) ≤35%, 0.89 for LVEF <45% and 0.87 for LVEF <50%. For LVEF ≤35%, AUC was higher in Black (0.95) and Hispanic (0.98) women compared to white (0.91). Natriuretic peptides and the multivariable model had AUCs of 0.85 and 0.72 respectively. Conclusions A deep learning model effectively identifies cardiomyopathy in pregnant or postpartum women, outperforms natriuretic peptides and traditional clinical parameters with the potential to become a powerful initial screening tool for cardiomyopathy in the obstetric care setting. Funding Acknowledgement Type of funding sources: Other. Main funding source(s): This study was made possible using resources supported by the Mayo Clinic Women's Health Research Center and the Mayo Clinic Building Interdisciplinary Research Careers in Women's Health (BIRCWH) Program funded by the National Institutes of Health (NIH), grant number K12 HD065987. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Uterine Fibroids: Hiding in Plain Sight
Nowak, Romana A. , Stewart, E A , Stewart, Elizabeth A.

Mayo Clinic

Physiology | December 29, 2021 | Volume: 37 | Issue: 1 | Pages: 16-27

10.1152/physiol.00013.2021 | PMID 34964688 Get It

Uterine fibroids (leiomyomas) are present in >75% of women and can cause serious morbidity. They are by far the leading cause of hysterectomy. Fibroids are a complex mixture of cells that include fibroblasts and smooth muscle cells. Rich in extracellular matrix, they typically arise through somatic mutations, most commonly MED12. Their lack of growth inhibition and their ability to have facets of malignancy yet be histologically and biologically benign provide opportunities to explore basic processes. To date, the mechanisms responsible for growth and development of leiomyomas are an enigma. This review provides an overview of current understanding and future directions for clinical and basic research of fibroids.
Artificial Intelligence and Atrial Fibrillation
Sehrawat, Ojasav , Kashou, Anthony H. , Noseworthy, Peter A.

Mayo Clinic

No container title available | December 29, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.164080022.21417996/v1 Get It

In the context of atrial fibrillation (AF), traditional clinical practices have thus far fallen short in several domains such as identifying patients at risk of incident AF or patients with concomitant undetected paroxysmal AF. Novel approaches leveraging artificial intelligence have the potential to provide new tools to deal with some of these old problems. In this review we focus on the roles of artificial intelligence-enabled ECG pertaining to AF, potential roles of deep learning (DL) models in the context of current knowledge gaps, as well as limitations of these models. One key area where DL models can translate to better patient outcomes is through automated ECG interpretation. Further, we overview some of the challenges facing AF screening and the harms and benefits of screening. In this context, a unique model was developed to detect underlying hidden AF from sinus rhythm and is discussed in detail with its potential uses. Knowledge gaps also remain regarding the best ways to monitor patients with ESUS and who would benefit most from oral anticoagulation. The AI-enabled AF model is one potential way to tackle this complex problem as it could be used to identify a subset of high-risk ESUS patients likely to benefit from empirical oral anticoagulation. Role of DL models assessing AF burden from long duration ECG data is also discussed as a way of guiding management. There is a trend towards the use of consumer-grade wristbands and watches to detect AF from photoplethysmography data. However, ECG currently remains the gold standard to detect arrythmias including AF. Lastly, role of adequate external validation of the models and clinical trials to study true performance is discussed.